Aditxt's Ignite Proteomics and Copley Acquisition mutually terminate SPAC merger

Aditxt, Inc.

Mutual Termination Agreement dated Oct 9, 2026 ends the June 10, 2026 Business Combination Agreement between Ignite Proteomics, LLC (Aditxt subsidiary) and Copley Acquisition Corp.
All ancillary documents automatically terminated, including Seller Support Agreements, Insider Letter Amendment and Lock-Up Agreements; only Sections 6.14, 6.15, 8.2, 9.1 and Article X survive.
Each party bears its own expenses instead of the BCA's Section 8.3 allocation; mutual releases cover all BCA-related claims, except claims under the Termination Agreement.
BCA had a Sept 30, 2026 Outside Date with one automatic 30-day extension; boards of Copley, Ignite Proteomics Holdings and Ignite determined termination was in their equity holders' best interest.
Signed by Aditxt interim CEO Jeffrey M. Busch (Ignite CEO and Seller Representative) and Chibo Tang for Copley, Pubco and both merger subs.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.